Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

References for PMC Articles for PubMed (Select 22996664)

1.

Genetic engineering of attenuated malaria parasites for vaccination.

Khan SM, Janse CJ, Kappe SH, Mikolajczak SA.

Curr Opin Biotechnol. 2012 Dec;23(6):908-16. doi: 10.1016/j.copbio.2012.04.003. Epub 2012 May 4. Review.

PMID:
22560204
2.

Analysis of malaria parasite phenotypes using experimental genetic crosses of Plasmodium falciparum.

Ranford-Cartwright LC, Mwangi JM.

Int J Parasitol. 2012 May 15;42(6):529-34. doi: 10.1016/j.ijpara.2012.03.004. Epub 2012 Mar 29. Review.

3.

Malaria parasite pre-erythrocytic infection: preparation meets opportunity.

Lindner SE, Miller JL, Kappe SH.

Cell Microbiol. 2012 Mar;14(3):316-24. doi: 10.1111/j.1462-5822.2011.01734.x. Epub 2012 Jan 9. Review.

4.

Macrophages prevent human red blood cell reconstitution in immunodeficient mice.

Hu Z, Van Rooijen N, Yang YG.

Blood. 2011 Nov 24;118(22):5938-46. doi: 10.1182/blood-2010-11-321414. Epub 2011 Sep 16.

5.

Hostile takeover by Plasmodium: reorganization of parasite and host cell membranes during liver stage egress.

Graewe S, Rankin KE, Lehmann C, Deschermeier C, Hecht L, Froehlke U, Stanway RR, Heussler V.

PLoS Pathog. 2011 Sep;7(9):e1002224. doi: 10.1371/journal.ppat.1002224. Epub 2011 Sep 1.

6.

Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites.

Mikolajczak SA, Sacci JB Jr, De La Vega P, Camargo N, VanBuskirk K, Krzych U, Cao J, Jacobs-Lorena M, Cowman AF, Kappe SH.

Cell Microbiol. 2011 Aug;13(8):1250-60. doi: 10.1111/j.1462-5822.2011.01617.x. Epub 2011 Jun 24.

7.

Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery.

Dembele L, Gego A, Zeeman AM, Franetich JF, Silvie O, Rametti A, Le Grand R, Dereuddre-Bosquet N, Sauerwein R, van Gemert GJ, Vaillant JC, Thomas AW, Snounou G, Kocken CH, Mazier D.

PLoS One. 2011 Mar 31;6(3):e18162. doi: 10.1371/journal.pone.0018162.

8.

Further improvements of the P. falciparum humanized mouse model.

Arnold L, Tyagi RK, Meija P, Swetman C, Gleeson J, Pérignon JL, Druilhe P.

PLoS One. 2011 Mar 31;6(3):e18045. doi: 10.1371/journal.pone.0018045.

9.

Plasmodium pyruvate dehydrogenase activity is only essential for the parasite's progression from liver infection to blood infection.

Pei Y, Tarun AS, Vaughan AM, Herman RW, Soliman JM, Erickson-Wayman A, Kappe SH.

Mol Microbiol. 2010 Feb;75(4):957-71. doi: 10.1111/j.1365-2958.2009.07034.x.

PMID:
20487290
10.

Plasmodium falciparum PF10_0164 (ETRAMP10.3) is an essential parasitophorous vacuole and exported protein in blood stages.

Mackellar DC, O'Neill MT, Aly AS, Sacci JB Jr, Cowman AF, Kappe SH.

Eukaryot Cell. 2010 May;9(5):784-94. doi: 10.1128/EC.00336-09. Epub 2010 Mar 12.

11.

Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment.

Bissig KD, Wieland SF, Tran P, Isogawa M, Le TT, Chisari FV, Verma IM.

J Clin Invest. 2010 Mar;120(3):924-30. doi: 10.1172/JCI40094. Epub 2010 Feb 22.

12.

A Plasmodium falciparum strain expressing GFP throughout the parasite's life-cycle.

Talman AM, Blagborough AM, Sinden RE.

PLoS One. 2010 Feb 10;5(2):e9156. doi: 10.1371/journal.pone.0009156.

13.

Advances and challenges in malaria vaccine development.

Wang R, Smith JD, Kappe SH.

Expert Rev Mol Med. 2009 Dec 16;11:e39. doi: 10.1017/S1462399409001318.

14.

Genetically engineered, attenuated whole-cell vaccine approaches for malaria.

Vaughan AM, Wang R, Kappe SH.

Hum Vaccin. 2010 Jan;6(1):107-13. Epub 2010 Jan 29. Review.

15.

Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design.

VanBuskirk KM, O'Neill MT, De La Vega P, Maier AG, Krzych U, Williams J, Dowler MG, Sacci JB Jr, Kangwanrangsan N, Tsuboi T, Kneteman NM, Heppner DG Jr, Murdock BA, Mikolajczak SA, Aly AS, Cowman AF, Kappe SH.

Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13004-9. doi: 10.1073/pnas.0906387106. Epub 2009 Jul 22.

16.

Humanized mice for modeling human infectious disease: challenges, progress, and outlook.

Legrand N, Ploss A, Balling R, Becker PD, Borsotti C, Brezillon N, Debarry J, de Jong Y, Deng H, Di Santo JP, Eisenbarth S, Eynon E, Flavell RA, Guzman CA, Huntington ND, Kremsdorf D, Manns MP, Manz MG, Mention JJ, Ott M, Rathinam C, Rice CM, Rongvaux A, Stevens S, Spits H, Strick-Marchand H, Takizawa H, van Lent AU, Wang C, Weijer K, Willinger T, Ziegler P.

Cell Host Microbe. 2009 Jul 23;6(1):5-9. doi: 10.1016/j.chom.2009.06.006. Review.

17.

Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes.

Jiménez-Díaz MB, Mulet T, Viera S, Gómez V, Garuti H, Ibáñez J, Alvarez-Doval A, Shultz LD, Martínez A, Gargallo-Viola D, Angulo-Barturen I.

Antimicrob Agents Chemother. 2009 Oct;53(10):4533-6. doi: 10.1128/AAC.00519-09. Epub 2009 Jul 13.

18.

A newly discovered protein export machine in malaria parasites.

de Koning-Ward TF, Gilson PR, Boddey JA, Rug M, Smith BJ, Papenfuss AT, Sanders PR, Lundie RJ, Maier AG, Cowman AF, Crabb BS.

Nature. 2009 Jun 18;459(7249):945-9. doi: 10.1038/nature08104.

19.

Type II fatty acid synthesis is essential only for malaria parasite late liver stage development.

Vaughan AM, O'Neill MT, Tarun AS, Camargo N, Phuong TM, Aly AS, Cowman AF, Kappe SH.

Cell Microbiol. 2009 Mar;11(3):506-20. doi: 10.1111/j.1462-5822.2008.01270.x. Epub 2008 Dec 3.

20.

Malaria parasite pre-erythrocytic stage infection: gliding and hiding.

Vaughan AM, Aly AS, Kappe SH.

Cell Host Microbe. 2008 Sep 11;4(3):209-18. doi: 10.1016/j.chom.2008.08.010. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk